CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Revenues [Abstract]
Revenue	$ 0	$ 0	$ 0	$ 0
Operating expenses:
Research and development	23,402	12,643	47,802	21,164
General and administrative	9,207	3,285	17,241	6,046
Total operating expenses	32,609	15,928	65,043	27,210
Loss from operations	(32,609)	(15,928)	(65,043)	(27,210)
Other income, net	518	1	567	2
Net loss	(32,091)	(15,927)	(64,476)	(27,208)
Other comprehensive loss:
Unrealized loss on marketable securities	218		242
Comprehensive loss	$ (32,309)	$ (15,927)	$ (64,718)	$ (27,208)
Net loss per share attributable to common stockholders - basic	$ (0.88)	$ (36.42)	$ (2.24)	$ (70.20)
Net loss per share attributable to common stockholders - diluted	$ (0.88)	$ (36.42)	$ (2.24)	$ (70.20)
Weighted-average common shares outstanding - basic	36,609,772	437,258	28,729,029	387,556
Weighted-average common shares outstanding - diluted	36,609,772	437,258	28,729,029	387,556